Subpage Banner Image

Bozeman Health Medical Group


Receiving a diagnosis of cancer can be a startling moment, but now, thanks to an enormous number of cancer drugs being tested around the world, patients can be part of the search for better treatments, and ultimately a cure.

Bozeman Deaconess Cancer Center offers patients access to numerous clinical trials thanks in part to its membership with the Montana Cancer Control Coalition (MTCCC). MTCCC is a statewide collaborative effort of individuals and organizations working to reduce the burden of cancer for Montanans by addressing issues from prevention and early detection to survivorship to enhance the odds of survivorship through prevention, early detection and state-of-the-art cancer care.

“Clinical trials are another set of tools we use in the fight against cancer,” said Spencer Green, manager of Bozeman Deaconess Cancer Center. “Without trials, we don’t come up with new treatments or get closer to cures.”

These research studies test new methods of treatment, prevention, diagnosis, screening and managing symptoms. In addition to helping scientists learn more about cancer, patients participating in clinical trials have access to promising treatments not yet offered outside of a clinical trial setting. About 90 clinical trials for dozens of different cancers are available in Montana. In Bozeman, 15 patients took advantage of such studies last year, and the number keeps growing.

Your primary care physician or oncologist can provide you with more information about participating in a clinical trial at Bozeman Deaconess Cancer Center. To find out more about cancer clinical trials, visit
Categories: Bozeman Health Medical Group